ஹோல்டிங்ஸ் வரையறுக்கப்பட்டவை தி நிறுவனம் இல் ஹாங் காங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange
CAMBRIDGE, Mass. and SUZHOU, China, Dec. 17, 2020 /PRNewswire/ HBM Holdings Limited ( Harbour BioMed , HBM or the Company ; Stock Code: 02142.HK), a global clinical-stage biopharmaceutical company, completed its global offering (the Global Offering ) and its listing on the Main Board of the Stock Exchange of Hong Kong Limited (the Stock Exchange ). The number of offer shares under the Global Offering is a total of 138,221,000 shares at a price of HK $12.38 per share, raising HK$1,711 million (USD$221 million) in total (before exercise of the over-allotment option in connection with the Global Offering). The offering was completed on December 10 ....

United States , Hong Kong , District Of Columbia , United Kingdom , United Kingdom General , Jingsong Wang , Anlan Fund , Morgan Stanley Asia , Capital Markets , China International Capital Corporation Hong Kong Securities , Blackrock Fund , Credit Suisse Hong Kong , Merrill Lynch Far East , Hong Kong Stock Exchange , Holdings Limited The Company In Hong Kong , Orbimed Fund , Holdings Limited Harbour Biomed , Merrill Lynch Asia Pacific , Stock Code , Main Board , Stock Exchange , Hong Kong Limited , Global Offering , Stanley Asia Limited , Merrill Lynch Far East Limited , Markets Limited ,